Atria Wealth Solutions Inc. Purchases 9,444 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Atria Wealth Solutions Inc. lifted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 40.8% in the 4th quarter, Holdings Channel.com reports. The fund owned 32,583 shares of the company’s stock after buying an additional 9,444 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in GE HealthCare Technologies were worth $2,547,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. LGT Financial Advisors LLC lifted its holdings in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies in the 3rd quarter worth about $26,000. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Darwin Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies in the third quarter worth approximately $31,000. Finally, Continuum Advisory LLC raised its holdings in shares of GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

NASDAQ:GEHC opened at $91.09 on Friday. The stock has a 50-day simple moving average of $85.05 and a two-hundred day simple moving average of $85.83. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80. The firm has a market capitalization of $41.66 billion, a PE ratio of 21.04, a P/E/G ratio of 3.20 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. Analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently issued reports on GEHC. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Finally, Citigroup increased their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.